Articles from: BioPharm International (BPI)
 |
|
|
| Next Page
| |
|
| Waters - Size-Exclusion Ultra Performance Liquid Chromatography for the Ana (more) | 2012 04 19 |
|
| Podcast: Efficient and Effective Approaches to Managing Raw Material Method (more) | 2012 04 19 |
|
|
|
|
| FDA Issues Final Guidance for Media Fills for Validation of Aseptic Prepara (more) | 2012 04 15 |
|
|
|
|
|
|
|
| GPhA Urges Congress to Move Ahead on Generic-Drug and Biosimilar User Fees (more) | 2012 04 11 |
|
|
|
| Bio-G Whitepaper: Biomanufacturing Debottlenecking and Process Optimization (more) | 2012 04 07 |
|
|
|
|
| Preparing for an FDA Inspection in a Global Pharmaceutical Environment (more) | 2012 04 07 |
|
| Guidelines for Routine Use and Maintenance of Ultra-Performance Size-Exclus (more) | 2012 04 07 |
|
|
|
|
|
|
|
| Knowledge Management Implementation in a Biopharmaceutical Company (more) | 2012 04 07 |
|
|
|
|
| Separation of Schizandrin, Schizandrin A, and Schizandrin B in a Tablet Sam (more) | 2012 04 07 |
|
|
|
|
| GlaxoSmithKline Plans Biopharmaceutical Manufacturing Investment in the UK (more) | 2012 04 03 |
|
| Waters, NIBRT Partner to Grow Knowledge of Large-Molecule Characterization (more) | 2012 04 03 |
|
|
|
|
|
| Bio-G Whitepaper: Biomanufacturing Debottlenecking and Process Optimization (more) | 2012 03 30 |
|
|
|
| Separation of Schizandrin, Schizandrin A, and Schizandrin B in a Tablet Sam (more) | 2012 03 30 |
|
|
|
| Pall Life Sciences - Implementation of Mustang® Q Membrane Chromato (more) | 2012 03 22 |
|
|
| Next Page
| |